P46061 (RAGP1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ran GTPase-activating protein 1 Short name=RanGAP1 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 589 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | GTPase activator for the nuclear Ras-related regulatory protein Ran, converting it to the putatively inactive GDP-bound state. Required for postimplantation development. Ref.5 Ref.6 Ref.8 |
| Subunit structure | Homodimer. Interacts with TRAF6 By similarity. Forms a tight complex in association with RANBP2/NUP358 and UBE2I/UBC9, the ubiquitin-conjugating enzyme E2. Interacts with UBE2I; the interaction conjugates SUMO1 to RANGAP1, and subsequently stabilizes interactions of sumoylated RANGAP1 with RANBP2/NUP358. The SUMO1/RANGAP1/UBC9/NUP358 complex associates with nuclear pore complexes. |
| Subcellular location | Cytoplasm By similarity. Nucleus membrane; Peripheral membrane protein; Cytoplasmic side By similarity. Chromosome › centromere › kinetochore By similarity. Cytoplasm › cytoskeleton › spindle By similarity. Note: Cytoplasmic during interphase. Targeted to the nuclear rim after sumoylation. During mitosis, associates with mitotic spindles. Association with kinetochores appears soon after nuclear envelope breakdown and persists until late anaphase. Mitotic location also requires sumoylation By similarity. Ref.5 Ref.6 Ref.8 |
| Post-translational modification | Phosphorylated occurs before nuclear envelope breakdown and continues throughout mitosis. Phosphorylated by the M-phase kinase cyclin B/Cdk1, in vitro. Differential timimg of dephosphorylation occurs during phases of mitosis. The phosphorylated form remains associated with RANBP2/NUP358 and the SUMO E2-conjugating enzyme, UBC9, on nuclear pore complex (NPC) diassembly and during mitosis. Ref.7 Sumoylated with SUMO1. Sumoylation is necessary for targeting to the nuclear envelope (NE), and for association with mitotic spindles and kinetochores during mitosis. Also required for interaction with RANBP2 and is mediated by UBC9 By similarity. Ref.5 Ref.6 Ref.8 |
| Sequence similarities | Belongs to the RNA1 family. Contains 6 LRR (leucine-rich) repeats. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | |||||||||||||||||||||||||
| Chain | 2 – 589 | 588 | Ran GTPase-activating protein 1 | PRO_0000056738 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Repeat | 48 – 71 | 24 | LRR 1 | |||||||||||||||||||||||||
| Repeat | 111 – 134 | 24 | LRR 2 | |||||||||||||||||||||||||
| Repeat | 207 – 230 | 24 | LRR 3 | |||||||||||||||||||||||||
| Repeat | 235 – 258 | 24 | LRR 4 | |||||||||||||||||||||||||
| Repeat | 292 – 315 | 24 | LRR 5 | |||||||||||||||||||||||||
| Repeat | 320 – 343 | 24 | LRR 6 | |||||||||||||||||||||||||
| Motif | 525 – 528 | 4 | SUMO conjugation By similarity | |||||||||||||||||||||||||
| Compositional bias | 359 – 399 | 41 | Asp/Glu-rich (highly acidic) | |||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||
| Site | 564 | 1 | Hydrophobic interaction with UBC9 By similarity | |||||||||||||||||||||||||
| Site | 567 | 1 | Hydrophobic interaction with UBC9 By similarity | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | |||||||||||||||||||||||||
| Modified residue | 358 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 411 | 1 | Phosphothreonine; by CDK2 By similarity | |||||||||||||||||||||||||
| Modified residue | 430 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 437 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 438 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||
| Modified residue | 444 | 1 | Phosphoserine Ref.7 Ref.9 | |||||||||||||||||||||||||
| Modified residue | 526 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||
| Cross-link | 8 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | ||||||||||||||||||||||||||
| Cross-link | 526 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.5 Ref.6 Ref.8 | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||
| Mutagenesis | 411 | 1 | T → D: Greatly reduced phosphorylation by CDK1 or CDK2. Completely abolished phosphorylation by CDK1 or CDK2; when associated with D-444. Ref.7 | |||||||||||||||||||||||||
| Mutagenesis | 444 | 1 | S → D: Little change in phosphorylation by CDK1 or CDK2. Completely abolished phosphorylation by CDK1 or CDK2; when associated with D-411. Ref.7 | |||||||||||||||||||||||||
| Mutagenesis | 512 | 1 | N → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 516 | 1 | T → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 517 | 1 | R → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 520 | 1 | I → A: No effect on UBC9 binding nor on sumoylation. | |||||||||||||||||||||||||
| Mutagenesis | 521 | 1 | H → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 522 | 1 | M → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 524 | 1 | L → A: No sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 525 | 1 | L → A: Disrupted binding of UCB9, and no sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 526 | 1 | K → A: No UBC9 binding nor sumoylation. Ref.5 Ref.6 Ref.8 Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 526 | 1 | K → R: Absence of sumoylation. Not targeted to the nuclear envelope rim nor to nuclear pore complexes. Disrupted sumoylation. No interaction with SUMO1; when associated with A-564 and with or without SUMO1 A-97. Ref.5 Ref.6 Ref.8 Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 528 | 1 | E → A: No UBC9 binding nor sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 529 | 1 | D → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 531 | 1 | I → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 537 | 1 | L → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 560 | 1 | L → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 563 | 1 | A → L: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 564 | 1 | F → A: No UBC9 binding nor sumoylation. Not targeted to nuclear core complexes; when associated with R-526. Ref.6 Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 567 | 1 | K → A: No UBC9 binding nor sumoylation. Ref.10 | |||||||||||||||||||||||||
| Mutagenesis | 569 | 1 | N → A: No effect on UBC9 binding nor on sumoylation. Ref.10 | |||||||||||||||||||||||||
| Sequence conflict | 181 | 1 | A → R in AAA17681. Ref.1 | |||||||||||||||||||||||||
| Sequence conflict | 413 | 1 | S → L in AAB60517. Ref.2 | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Helix | 436 – 441 | 6 | ||||||||||||||||||||||||||
| Helix | 445 – 450 | 6 | ||||||||||||||||||||||||||
| Helix | 455 – 461 | 7 | ||||||||||||||||||||||||||
| Helix | 468 – 480 | 13 | ||||||||||||||||||||||||||
| Helix | 486 – 505 | 20 | ||||||||||||||||||||||||||
| Helix | 511 – 521 | 11 | ||||||||||||||||||||||||||
| Helix | 538 – 549 | 12 | ||||||||||||||||||||||||||
| Helix | 555 – 557 | 3 | ||||||||||||||||||||||||||
| Helix | 558 – 565 | 8 | ||||||||||||||||||||||||||
| Helix | 577 – 588 | 12 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A murine homolog of the yeast RNA1 gene is required for postimplantation development." Degregori J., Russ A., von Melchner H., Rayburn H., Priyaranjan P., Jenkins N.A., Copeland N.G., Ruley H.E. Genes Dev. 8:265-276(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Separate domains of the Ran GTPase interact with different factors to regulate nuclear protein import and RNA processing." Ren M., Villamarin A., Shih A., Coutavas E., Moore M.S., Locurcio M., Clarke V., Oppenheim J.D., D'Eustachio P., Rush M.G. Mol. Cell. Biol. 15:2117-2124(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Strain: BALB/c. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6J. Tissue: Liver and Visual cortex. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: 129 and C57BL/6J. Tissue: Mammary tumor. |
| [5] | "Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association." Mahajan R., Gerace L., Melchior F. J. Cell Biol. 140:259-270(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-526, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-526. |
| [6] | "SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex." Matunis M.J., Wu J., Blobel G. J. Cell Biol. 140:499-509(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-526, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-526 AND PHE-564. |
| [7] | "RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly." Swaminathan S., Kiendl F., Koerner R., Lupetti R., Hengst L., Melchior F. J. Cell Biol. 164:965-971(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-411 AND SER-444, MUTAGENESIS OF THR-411 AND SER-444. |
| [8] | "SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes." Zhu S., Zhang H., Matunis M.J. Exp. Cell Res. 312:1042-1049(2006) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-526, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-526. |
| [9] | "Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry." Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J. Mol. Cell. Proteomics 8:904-912(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-444, MASS SPECTROMETRY. Tissue: Embryonic fibroblast. |
| [10] | "Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1." Bernier-Villamor V., Sampson D.A., Matunis M.J., Lima C.D. Cell 108:345-356(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 420-589 IN COMPLEX WITH SUMO1 AND HUMAN UBE2I, MUTAGENESIS OF ASN-512; THR-516; ARG-517; HIS-521; MET-522; LEU-524; LEU-525; LYS-526; GLU-528; ASP-529; ILE-531; LEU-537; LEU-560; ALA-563; PHE-564; LYS-567 AND ASN-569. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U08110 mRNA. Translation: AAA17681.1. U20857 Genomic RNA. Translation: AAB60517.1. AK146670 mRNA. Translation: BAE27347.1. AK159009 mRNA. Translation: BAE34767.1. AK159525 mRNA. Translation: BAE35154.1. BC066213 mRNA. Translation: AAH66213.1. BC071200 mRNA. Translation: AAH71200.1. | ||||||||||||
| IPI | IPI00467338. | ||||||||||||
| PIR | A36983. T52070. | ||||||||||||
| RefSeq | NP_001139646.1. NM_001146174.1. NP_035371.4. NM_011241.4. | ||||||||||||
| UniGene | Mm.270975. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P46061. | ||||||||||||
| SMR | P46061. Positions 21-370, 434-589. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-17024N. | ||||||||||||
| IntAct | P46061. 1 interaction. | ||||||||||||
| STRING | 10090.ENSMUSP00000057771. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P46061. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P46061. | ||||||||||||
| PRIDE | P46061. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000052374; ENSMUSP00000057771; ENSMUSG00000022391. ENSMUST00000170134; ENSMUSP00000126849; ENSMUSG00000022391. ENSMUST00000171115; ENSMUSP00000130046; ENSMUSG00000022391. | ||||||||||||
| GeneID | 19387. | ||||||||||||
| KEGG | mmu:19387. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5905. | ||||||||||||
| MGI | MGI:103071. Rangap1. | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5238. | ||||||||||||
| GeneTree | ENSGT00440000039203. | ||||||||||||
| HOVERGEN | HBG017720. | ||||||||||||
| InParanoid | Q6NZB5. | ||||||||||||
| KO | K14319. | ||||||||||||
| OMA | SFNSNAF. | ||||||||||||
| OrthoDB | EOG4K0QN7. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P46061. | ||||||||||||
| Bgee | P46061. | ||||||||||||
| CleanEx | MM_RANGAP1. | ||||||||||||
| Genevestigator | P46061. | ||||||||||||
| GermOnline | ENSMUSG00000022391. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.25.40.200. 1 hit. | ||||||||||||
| InterPro | IPR009109. Ran_GTPase_activating_1_C. IPR027038. RanGap. [Graphical view] | ||||||||||||
| PANTHER | PTHR24113. PTHR24113. 1 hit. | ||||||||||||
| Pfam | PF07834. RanGAP1_C. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF69099. RanGAP1_C. 1 hit. | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | RANGAP1. mouse. | ||||||||||||
| EvolutionaryTrace | P46061. | ||||||||||||
| NextBio | 296501. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | RAGP1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P46061 Secondary accession number(s): Q60801, Q6NZB5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
